TerminatedPhase 4NCT03726996

Desipramine in Infantile Neuroaxonal Dystrophy (INAD).

Studying Infantile neuroaxonal dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Duke University
Principal Investigator
Yong-hui Jiang, MD
Duke University
Intervention
Desipramine(drug)
Enrollment
4 enrolled
Eligibility
3-17 years · All sexes
Timeline
20192019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03726996 on ClinicalTrials.gov

Other trials for Infantile neuroaxonal dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Infantile neuroaxonal dystrophy

← Back to all trials